Inhibitor Therapeutics, Inc. Provides Update on its Clinical Development Plan
22 août 2024 09h00 HE
|
Inhibitor Therapeutics, Inc.
TAMPA, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Inhibitor Therapeutics, Inc. ("Inhibitor") (OTCQB: INTI) today provided an update on development efforts for its itraconazole formulation for the...
Momentum for higher welfare broiler chicken grows as nine leading food businesses join the U.S. Working Group for Broiler Welfare
25 août 2022 06h00 HE
|
Compassion in World Farming USA
New York City, NY, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Nine new leading food businesses join the U.S. Working Group for Broiler Welfare, bringing the group to 16 members. The doubling of members...
Biofrontera provides update on clinical developments
22 juin 2021 09h00 HE
|
Biofrontera AG
Leverkusen, Germany, June 22, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today provides an...
The Canadian Bioceutical Corporation Announces Name Change to MPX Bioceutical Corporation
02 nov. 2017 18h54 HE
|
The Canadian Bioceutical Corporation
Election of Board of DirectorsAppoint Deloitte LLP as AuditorAppointment of OfficersIssuance of Stock OptionsEntering into Executive Services Agreement with Canadian Capital, LLC TORONTO, Nov. 02,...
BCC Provides Update on Health Canada Licensed Producer Application and Owen Sound Facility Build Out
26 oct. 2017 07h00 HE
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 26, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced it has completed preparatory construction work and...
BCC Announces Initial US$10 Million Drawdown on Credit Facility
24 oct. 2017 18h20 HE
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 24, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that it made an initial drawdown of US$10 million under...
BCC Signs Definitive Agreement to Expand Into Second Adult Use Market
13 oct. 2017 07h00 HE
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that, the Company, through its wholly-owned U.S....
BCC Reports Q1 Fiscal 2018 Results
28 sept. 2017 21h35 HE
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 28, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) reported its financial results for the first quarter of fiscal 2018,...
BCC Reports Q4 and Fiscal 2017 Results
08 sept. 2017 07h00 HE
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 08, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today reported its financial results for the fourth quarter and full...
BCC to Enter Into Joint Venture With Israeli Pharmaceutical Company Panaxia
22 août 2017 07h00 HE
|
The Canadian Bioceutical Corporation
Differentiation into high-growth market segment under new “Salus Bio-Pharma” brand JV will launch in Arizona & Massachusetts and, post closing of the acquisitions, in Nevada and Maryland. ...